PFS Partners’s Labcorp LH Stock Holding History

PFS Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29	Closed	-$6.59K	–	361
2022 Q1	$6.59K	Hold	29	–	–	0.01%	240
2021 Q4	$7.86K	Buy	+29	New	+$7.18K	0.01%	229

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

PFS Partners's LH Position: Q2 2022 in Review

PFS Partners sold out of Labcorp (LH) in Q2 2022, closing a stake of 29 shares — an estimated $6.59K sold.

PFS Partners first reported a position in LH in Q4 2021 and held it in 2 quarters. The position peaked at $7.86K in Q4 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

PFS Partners reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
PFS Partners sold 29 Labcorp shares in Q2 2022, an estimated $6.59K.
PFS Partners first reported a position in Labcorp in Q4 2021 and held it in 2 quarters.
PFS Partners's Labcorp position peaked at $7.86K in Q4 2021.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on PFS Partners's 13F filing for Q2 2022, filed 1 Dec 2023.